Drug Shortage Report for PRALUENT
| Report ID | 80305 |
| Drug Identification Number | 02453819 |
| Brand name | PRALUENT |
| Common or Proper name | Praluent Pen 75mg/mL |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALIROCUMAB |
| Strength(s) | 75MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 2 pre-filled pens |
| ATC code | C10AX |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-04-15 |
| Actual start date | |
| Estimated end date | 2019-05-06 |
| Actual end date | 2019-04-17 |
| Shortage status | Resolved |
| Updated date | 2019-04-18 |
| Company comments | TEMPORARY SHORTAGE OF PRALUENT, 75mg/mL & 150mg/mL (Alirocumab) We recognize the difficulties that this situation may cause for patients and health care providers. We apologize for any inconvenience resulting from this. Please note that both strengths (75 mg/mL and 150mg/mL) are not equivalent. For more information, please contact your healthcare professional. All efforts are being made to resolve the situation and any update will be communicated on the www.drugshortagescanada.ca website. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-04-18 | French | Compare |
| v4 | 2019-04-18 | English | Compare |
| v3 | 2019-04-16 | English | Compare |
| v2 | 2019-04-02 | French | Compare |
| v1 | 2019-04-02 | English | Compare |
Showing 1 to 5 of 5